Literature DB >> 35981961

An outbreak of acute respiratory disease caused by HAdV-55 in Beijing, China, 2020.

HongBo Liu1, Qingfeng Li2, Ying Xiang1, Hong Li2, Kangkang Liu1, Xinying Du1, Chaojie Yang1, Hongbo Liu1, Mengjing Shi2, Xueqian Hu2, Hui Wang1, Xiaohong Zhang2, Xiangda Li2, Sai Tian1, Renlong Bao1, Ligui Wang1, Shaofu Qiu1, Hongbin Song1.   

Abstract

Human adenoviruses (HAdVs) can cause acute respiratory diseases (ARDs) worldwide, and HAdV-55 is a reemergent pathogen in recent years. In the study, we investigated an outbreak of ARD at a school due to HAdV-55 in Beijing, China, during the early outbreak of coronavirus disease 2019 (COVID-19). The epidemic prevention team was dispatched to the school to collect epidemiologic data and nasopharyngeal samples. Then, real-time reverse transcription polymerase chain reaction (PCR) and multiplex PCR assays were used to detect severe acute respiratory syndrome coronavirus 2 and other respiratory pathogens, respectively. One representative HAdV-55 isolate was selected and submitted for whole-genome sequencing using a MiSeq system and the whole-genome phylogenetic tree was conducted based on the maximum likelihood method. The outbreak lasted from January 27 to February 6, 2020, and 108 students developed fever, among whom 60 (55.56%) cases were diagnosed with HAdV-55 infection in the laboratory using real-time PCR and 56 cases were hospitalized. All the confirmed cases had a fever and 11 cases (18.33%) presented with a fever above 39°C. Other main clinical symptoms included sore throat (43.33%) and headache (43.33%). We obtained and assembled the full genome of one isolate, BJ-446, with 34 761 nucleotides in length. HAdV-55 isolate BJ-446 was 99.85% identical to strain QS-DLL, which was the first HAdV-55 strain in China isolated from an ARD outbreak in Shanxi in 2006. One and four amino acid mutations were observed in the hexon gene and the coding region of L2 pV 40.1 kDa protein, respectively. We identified the first HAdV-55 infection associated with the ARD outbreak in Beijing since the emergence of COVID-19. The study suggests that improved surveillance of HAdV is needed, although COVID-19 is still prevalent in the world.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  China; HAdV-55; acute respiratory disease; outbreak

Mesh:

Substances:

Year:  2022        PMID: 35981961     DOI: 10.1002/jmv.28074

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   20.693


  1 in total

1.  Prevention and Treatment of Monkeypox.

Authors:  John G Rizk; Giuseppe Lippi; Brandon M Henry; Donald N Forthal; Youssef Rizk
Journal:  Drugs       Date:  2022-06-28       Impact factor: 11.431

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.